Business Context and Reporting Period
Company: Amphastar Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2015
Reporting Period: Quarter ended September 30, 2015
This filing serves as a notification that the company issued a press release announcing its financial results for the third quarter of 2015. The detailed financial data is contained within the attached press release (Exhibit 99.1) and is not embedded directly in the text of this 8-K form.
Key Financial Metrics
The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the press release furnished as Exhibit 99.1.
Material Changes
No material changes or comparative financial data are disclosed within the body of this filing. The document solely references the issuance of the quarterly results announcement.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that management has released a press update regarding the quarter ended September 30, 2015.
Legal Disclaimer: The information in this report, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2015) for specific revenue, net income, and EPS figures.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any forward-looking statements or guidance updates included in the press release.
- Confirm the company's cash position and debt levels as reported in the full quarterly results.